| Patents for C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442) |
|---|
| 08/07/2002 | CN1362963A 3-deoxy-desmycosin derivatives and process for their preparation |
| 08/07/2002 | CN1362959A C10 carbamoyloxy substituted taxanes as antitumor agents |
| 08/07/2002 | CN1362958A C7 carbonate substituted taxanes as antitumor agents |
| 08/07/2002 | CN1362957A C17 heterosubustituted acetate taxanes as antitumor agents |
| 08/07/2002 | CN1362956A C7 carbamoyloxy substituted taxanes as antitumor agents |
| 08/07/2002 | CN1362955A C7 ester substituted taxanes as antitumor agents |
| 08/07/2002 | CN1362876A C10 heterosubstituted acetate taxanes as antitumor agents |
| 08/07/2002 | CN1088703C Water soluble of taxad alcohol derivative |
| 08/06/2002 | US6429232 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 08/01/2002 | US20020103330 Naphthalene derivative, binaphthalene derivative and biphenyl derivative and cationically curable compound |
| 07/31/2002 | EP1227093A2 Beta-lactams useful for preparation of taxanes having furyl or thienyl substituted side-chain |
| 07/25/2002 | WO2002044161A3 A process for the preparation of taxan derivatives |
| 07/24/2002 | EP0741716B1 Delta 12,13 -iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them |
| 07/17/2002 | EP0882231B1 Recovery of taxanes from conifers |
| 07/17/2002 | CN1359384A Taxane derivatives and processes for the preparation thereof |
| 07/11/2002 | US20020091274 Taxane derivatives having an amino substituted C13 side chain useful as antileukemia and antitumor agents |
| 07/10/2002 | EP1221445A1 Pentacyclic taxane compounds |
| 07/10/2002 | EP0738148B1 Self-assembled taxo-diperpenoid nanostructures |
| 07/09/2002 | US6417314 Fluorinated polyurethane elastomers prepared from polyether prepolymers formed from mono-substituted fluorinated oxetane monomers |
| 07/09/2002 | US6417181 Viricides formed by catalytic hydrogenation |
| 07/09/2002 | CA2126462C Method for preparing taxane derivatives |
| 07/04/2002 | WO2002051388A2 Treatment of inoperable tumors by stereotactic injection of microspheres |
| 07/04/2002 | US20020087026 Admixing an oxazole derivative with a base and a compound composed of an alcohol and/or an alkoxide |
| 07/04/2002 | US20020087013 Methods for preparing new taxoids and pharmaceutical compositions containing them |
| 07/04/2002 | US20020086897 Cytotoxic agents comprising taxanes and their therapeutic use |
| 07/04/2002 | CA2432518A1 Treatment of inoperable tumors by stereotactic injection of microspheres |
| 07/03/2002 | EP0681573B1 C2 Taxane derivatives and pharmaceutical compositions containing them |
| 07/03/2002 | CN1356992A Process for extraction and purification of paclitaxel from natural sources |
| 07/03/2002 | CN1356326A Process for selectively protecting baccatin derivative and its application in synthesizing tartrialkane |
| 07/03/2002 | CN1356325A Process for selectively protecting baccatin derivative and its application in synthesizing tartrialkane |
| 06/27/2002 | US20020081339 Biodegradable microspheres releasing an anticancer agent are injected into the tumor, into the peritumoral area or both at the same time |
| 06/25/2002 | US6410757 Taxane compounds |
| 06/25/2002 | US6410756 Family of Canadensol taxanes, the semi-synthetic preparation and therapeutic use thereof |
| 06/20/2002 | WO2002010129A3 Materials that can be structured, method for producing the same and their use |
| 06/20/2002 | US20020077341 C10 carbamoyloxy substituted taxanes |
| 06/20/2002 | US20020077316 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; Alzheimer's Disease; Syndrome X; peroxisome proliferator activated receptor-associated disorder |
| 06/19/2002 | EP1214061A2 Use of docetaxel for treating hepatocellular carcinoma |
| 06/18/2002 | US6407268 Herbicides |
| 06/13/2002 | WO2002046177A1 A process for the preparation of paclitaxel |
| 06/13/2002 | WO2001097618A3 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 06/12/2002 | EP1178979A4 NOVEL REACTION CONDITIONS FOR THE CLEAVAGE OF SILYL ETHERS IN THE PREPARATION OF PACLITAXEL (TAXOL$m(3)) AND PACLITAXEL ANALOGUES |
| 06/12/2002 | EP1068192B1 Novel crystalline complexes of baccatin iii with imidazole, 2-methylimidazole or isopropanol |
| 06/12/2002 | EP0688212B1 C9 taxane derivatives and pharmaceutical compositions containing them |
| 06/11/2002 | US6403635 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 06/06/2002 | WO2002044162A1 Chromatographic separation method of paclitaxel and cephalomannin |
| 06/06/2002 | WO2002044161A2 A process for the preparation of taxan derivatives |
| 06/06/2002 | US20020068833 Formed as enantiomers of cis-beta-phenylglycidic acid/beta-phenylisoserine react with nitrile compound via Ritter reaction |
| 06/06/2002 | US20020068755 Antitumor agents. |
| 06/06/2002 | US20020068723 Altering the conformational equilibrium of the A- ring to favor a chair conformation that presents the 1 alpha-hydroxyl in the axial orientation. |
| 06/05/2002 | EP1211250A1 C10 taxane derivatives and pharmaceutical compositions |
| 06/05/2002 | EP1105379B1 Water soluble analogs and prodrugs of paclitaxel |
| 06/05/2002 | EP0912536B1 Taxane hydroxy monoacylation method |
| 06/04/2002 | US6399783 Chemical intermediate for taxol |
| 05/30/2002 | US20020065305 As antitumor agent |
| 05/30/2002 | US20020065304 As antitumor agent |
| 05/29/2002 | EP0889885B1 Method for selective protection of baccatin derivatives and its application to taxane synthesis |
| 05/28/2002 | US6395895 Butenyl substituted β-lactams |
| 05/28/2002 | US6395771 Solvent solubility; side effect reduction |
| 05/22/2002 | EP1206461A1 Process for the preparation of a paclitaxel c-4 methyl carbonate analog |
| 05/22/2002 | EP0927175A4 1-deoxy baccatin iii, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof |
| 05/22/2002 | EP0681575B1 Process for the preparation of Baccatin III analogs bearing new C2 and C4 functional groups |
| 05/22/2002 | CN1349853A Lactone preparing catalyst and lactone preparing process |
| 05/21/2002 | US6392063 Hydrolysis-promoting hydrophobic taxane derivatives |
| 05/21/2002 | US6392061 Process for making (2S, 3S, 5S) oxetanone derivatives |
| 05/21/2002 | US6391913 Derivatives of paclitaxel, method for producing same and uses thereof |
| 05/16/2002 | WO2002038556A2 Process for mass production of gmp paclitaxel and related taxanes |
| 05/16/2002 | WO2002038555A1 Isolation of taxanes |
| 05/16/2002 | US20020058822 Process for making (2S, 3S, 5S) oxetanone derivatives |
| 05/16/2002 | US20020058821 C2 substituted taxanes |
| 05/16/2002 | CA2428654A1 Isolation of taxanes |
| 05/14/2002 | US6387946 Methods for treating pathological conditions of abnormal cell proliferation |
| 05/10/2002 | WO2002036582A1 Stable pharmaceutical form of an anticancer drug |
| 05/08/2002 | EP1155008A4 C-7 metal alkoxides of baccatin iii |
| 05/08/2002 | CN1347760A Ag-CuCl catalyst for the direct oxidation of propylene with air to prepare epoxypropane |
| 05/08/2002 | CN1084390C Method for mass production of taxol through semi-continuous culture |
| 05/07/2002 | US6384242 Geranic acid derivatives |
| 05/07/2002 | US6384071 Antitumor agents |
| 05/02/2002 | US20020052518 Taxane with a hydrocarbon having at the alpha position a group such as halogen at the 2' and/or 7 positions; enhanced in vivo hydrolysis for enhanced taxane therapeutic activity |
| 05/02/2002 | US20020052517 Synthesis of taxol, taxol analogs and their intermediates with variable a-ring side chain structures and compositions thereof |
| 05/02/2002 | US20020052403 Taxane formulations |
| 05/02/2002 | US20020051827 Supercritical extraction of taxanes |
| 05/02/2002 | EP1200424A1 C7 heterosubstituted acetate taxanes as antitumor agents |
| 05/02/2002 | EP0833628A4 Novel taxoids |
| 04/30/2002 | US6380351 Copolymers and coprepolymers formed from mono-substituted fluorinated oxetane monomers and tetrahydrofuran |
| 04/30/2002 | US6379552 Method for resolving optical isomers |
| 04/30/2002 | CA2088931C Phosphonooxy and carbonate derivatives of taxol |
| 04/25/2002 | WO2002032850A1 Process for making (2s, 3s, 5s) oxetanone derivatives |
| 04/24/2002 | CN1346362A Avermectin derivatives |
| 04/18/2002 | WO2002030884A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030882A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030863A2 Ether compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030860A2 Ketone compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2001057014A3 Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one |
| 04/18/2002 | US20020045771 Reacting 7-OH-protected baccatin III with 3-tert-butyl-2,2-dimethyl4-phenyloxazolidine-5-carboxylic acid |
| 04/18/2002 | US20020045767 Process for making (2s, 3s, 5s) oxetanone derivatives |
| 04/18/2002 | US20020045750 Asymetric hemisynthesis of harringtonines and their analogs, that are alkaloids used in chemotherapy. |
| 04/18/2002 | CA2425678A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | CA2425674A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | CA2425121A1 Ether compounds and compositions for cholesterol management and related uses |
| 04/17/2002 | EP0902783B1 Hydrolysis-promoting taxane hydrophobic derivatives |